Although the traumatic circumstances of the COVID-19 pandemic have exacerbated existing health inequities, it has also fueled an immediacy to address them. The CDC recently released two grant-funded initiatives for state and local health departments to mitigate COVID-19 related health disparities: With a combined estimated total program funding of $2.5 billion, many health departments will … Read more
Salt Lake City, March 31, 2021 –Today, Leavitt Partners is pleased to announce that Brett Giroir, MD has joined the firm as a Distinguished Visiting Executive. Dr. Giroir will focus on addressing important healthcare topics such as bio-preparedness, value-based care arrangements, evolving issues with the COVID-19 pandemic, diagnostic testing and more. Brett Giroir, MD is … Read more
Salt Lake City, March 16, 2021—Today, Leavitt Partners released “Using Modeling to Project Herd Immunity: When and how we will get back to normal,” a research paper outlining results from their current model to determine the expected timeline to reaching herd immunity from COVID-19. The research was conducted in response to growing interest in understanding … Read more
On Thursday, February 25, 2021, Leavitt Partners held a LinkedIn Live broadcast focused on using budget reconciliation to advance health policy change in Congress, featuring Andrew Croshaw, Liz Wroe and Sara Singleton from Leavitt Partners. They discussed President Biden’s healthcare priorities as well as what healthcare organizations can do to impact health-related legislation. President Biden … Read more
Salt Lake City, March 3, 2021–Leavitt Partners is pleased to announce that Jeremy Bahr has joined the firm as a Principal. Jeremy will focus on developing solutions that cross between the intersection of value and strategy, within the life sciences sector. He helps build brands, deliver insights, and lead business transformations. Since 2018, Jeremy has … Read more
2020 was a year that no one could have predicted with the onset of the pandemic and its impact to the U.S. economy. As we head into 2021, the end of pandemic is in sight. However, we continue to see pervasive daily increases in coronavirus cases, high death rates, and continued challenges around the rollout … Read more
Salt Lake City, December 14, 2020—Today, Leavitt Partners released “Addressing Health Disparities Among Racially & Culturally Diverse Populations in Utah During COVID-19,” a final report discussing the spotlight COVID-19 has put on health disparities in Utah and around the nation. The report was conducted in partnership with the Multicultural Advisory Committee of Utah’s COVID-19 Response … Read more
While we are still examining the 2020 election results and how voters’ personal experiences with the pandemic and financial upheaval influenced their decisions, Governor Leavitt made eight important observations about the election that will shape the ensuing healthcare policy environment. He recently discussed the following observations during Leavitt Partners’ biannual Political Checkpoint webinar. Observation #1: It … Read more
Cell and gene therapies (CGTs) are some of the most promising and exciting medical advancements taking place today. Some existing CGTs treat previously untreatable rare diseases, and there are hundreds of CGTs in clinical development to treat various types of cancer, hemophilia, sickle cell and other blood disorders, Alzheimer’s disease, and numerous rare conditions. The … Read more
Salt Lake City, August 18, 2020—Today Leavitt Partners announced the acquisition of Torch Insight® by Milliman, Inc. This acquisition will combine Torch Insight’s powerful market-centered data and analytics with MedInsight, Milliman’s flagship healthcare analytics ecosystem. Torch Insight brings Milliman decades of healthcare policy expertise and healthcare analytic experience backed by Leavitt Partners – recognized experts … Read more
